The potential and limitations of miR-150-3p as a cisplatin sensitizer in NSCLC: a comment on miR-150-3p enhances the sensitivity of non-small cell lung cancer to cisplatin by down-regulating the expression of AKT2
Ciappina G.
Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
giuliana.ciappina@unife.it
, Infurna C.
School of Specialization in Medical Oncology, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy
, Marafioti M.
School of Specialization in Medical Oncology, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy
Comments (0)